← Open Payments lookup

SARAH TOMASHEFSKI: Open Payments

NPI 1396271870 · GREENVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$16,874 in 66 payments from 15 companies in 2025. Trend: 2023 $953 · 2024 $3,160 · 2025 $16,874

Consulting: $11,830Food & beverage: $2,863Travel & lodging: $2,164Education: $17
CompanyPaymentsAmount
GENZYME CORPORATION25$11,624
GlaxoSmithKline, LLC.6$3,321
Insmed, Inc.4$487
United Therapeutics Corporation10$431
AstraZeneca Pharmaceuticals LP6$326
Regeneron Healthcare Solutions, Inc.1$128
Grifols Shared Services North America, Inc.1$118
Abbott Laboratories1$113
Grifols USA, LLC2$109
Boehringer Ingelheim Pharmaceuticals, Inc.3$68

Products named: DUPIXENT, Prolastin-C Liquid, STEEN SOLUTION, CARDIOMEMS, BREZTRI, FASENRA, TRELEGY ELLIPTA, JASCAYD.

Industry payments across SC — which companies pay providers there.